JP Morgan Chase’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

JP Morgan Chase’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-36,650	Closed	-$231K	–	4572
2013 Q2	$231K	Buy	+36,650	New	+$220K	﹤0.01%	3935

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

JP Morgan Chase's PBTH Position: Q3 2013 in Review

JP Morgan Chase sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 36,650 shares — an estimated $231K sold.

JP Morgan Chase first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $231K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

JP Morgan Chase reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
JP Morgan Chase sold 36,650 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $231K.
JP Morgan Chase first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
JP Morgan Chase's PROLOR Biotech, Inc. Common Stock position peaked at $231K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on JP Morgan Chase's 13F filing for Q3 2013, filed 31 Oct 2013.